Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors.

MLA

Bondarenko, Gennadiy, et al. “Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors.” Neoplasia (New York, N.Y.), vol. 17, no. 9, Sept. 2015, pp. 735–41. EBSCOhost, https://doi.org/10.1016/j.neo.2015.09.004.

APA

Bondarenko, G., Ugolkov, A., Rohan, S., Kulesza, P., Dubrovskyi, O., Gursel, D., Mathews, J., O’Halloran, T. V., Wei, J. J., & Mazar, A. P. (2015). Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors. Neoplasia (New York, N.Y.), 17(9), 735–741. https://doi.org/10.1016/j.neo.2015.09.004

Chicago

Bondarenko, Gennadiy, Andrey Ugolkov, Stephen Rohan, Piotr Kulesza, Oleksii Dubrovskyi, Demirkan Gursel, Jeremy Mathews, Thomas V O’Halloran, Jian J Wei, and Andrew P Mazar. 2015. “Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors.” Neoplasia (New York, N.Y.) 17 (9): 735–41. doi:10.1016/j.neo.2015.09.004.